166 related articles for article (PubMed ID: 23814490)
61. Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214.
Huang PS; Lin YH; Chi HC; Chen PY; Huang YH; Yeh CT; Wang CS; Lin KH
Sci Rep; 2017 Nov; 7(1):14868. PubMed ID: 29093516
[TBL] [Abstract][Full Text] [Related]
62. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.
Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF
Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186
[TBL] [Abstract][Full Text] [Related]
63. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
[TBL] [Abstract][Full Text] [Related]
64. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.
Duan Z; Gao Y; Shen J; Choy E; Cote G; Harmon D; Bernstein K; Lozano-Calderon S; Mankin H; Hornicek FJ
Mol Oncol; 2017 Feb; 11(2):151-166. PubMed ID: 28145098
[TBL] [Abstract][Full Text] [Related]
65. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.
Liu XY; Liu ZJ; He H; Zhang C; Wang YL
Am J Cancer Res; 2015; 5(10):3015-29. PubMed ID: 26693056
[TBL] [Abstract][Full Text] [Related]
67. Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer.
Zhao C; Wang G; Zhu Y; Li X; Yan F; Zhang C; Huang X; Zhang Y
Tumour Biol; 2016 Jan; 37(1):177-83. PubMed ID: 26586400
[TBL] [Abstract][Full Text] [Related]
68. Differential Effects of Hepatocyte Nuclear Factor 4α Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human Colorectal Cancer Cells.
Vuong LM; Chellappa K; Dhahbi JM; Deans JR; Fang B; Bolotin E; Titova NV; Hoverter NP; Spindler SR; Waterman ML; Sladek FM
Mol Cell Biol; 2015 Oct; 35(20):3471-90. PubMed ID: 26240283
[TBL] [Abstract][Full Text] [Related]
69. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.
Hollis M; Nair K; Vyas A; Chaturvedi LS; Gambhir S; Vyas D
World J Gastroenterol; 2015 Jul; 21(27):8284-92. PubMed ID: 26217080
[TBL] [Abstract][Full Text] [Related]
70. A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer.
Kim JE; Son JE; Jeong H; Joon Kim D; Seo SK; Lee E; Lim TG; Kim JR; Chen H; Bode AM; Lee KW; Dong Z
Cancer Res; 2015 Jul; 75(13):2716-2728. PubMed ID: 25948588
[TBL] [Abstract][Full Text] [Related]
71. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.
Chiam K; Wang T; Watson DI; Mayne GC; Irvine TS; Bright T; Smith L; White IA; Bowen JM; Keefe D; Thompson SK; Jones ME; Hussey DJ
J Gastrointest Surg; 2015 Jul; 19(7):1208-15. PubMed ID: 25943911
[TBL] [Abstract][Full Text] [Related]
72. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.
Zhang J; Jia J; Zhao L; Li X; Xie Q; Chen X; Wang J; Lu F
Mol Carcinog; 2016 May; 55(5):732-42. PubMed ID: 25809226
[TBL] [Abstract][Full Text] [Related]
73. Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma.
Zhu X; Xu JJ; Hu SS; Feng JG; Jiang LH; Hou XX; Cao J; Han J; Ling ZQ; Ge MH
J Exp Clin Cancer Res; 2014 Dec; 33(1):114. PubMed ID: 25551195
[TBL] [Abstract][Full Text] [Related]
74. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
[TBL] [Abstract][Full Text] [Related]
75. Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.
Brosius SN; Turk AN; Byer SJ; Longo JF; Kappes JC; Roth KA; Carroll SL
J Neuropathol Exp Neurol; 2014 Nov; 73(11):1078-90. PubMed ID: 25289889
[TBL] [Abstract][Full Text] [Related]
76. Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
Li YY; Mukaida N
World J Gastroenterol; 2014 Jul; 20(28):9392-404. PubMed ID: 25071334
[TBL] [Abstract][Full Text] [Related]
77. Cancer subclonal genetic architecture as a key to personalized medicine.
Rehemtulla A
Neoplasia; 2013 Dec; 15(12):1410-20. PubMed ID: 24403863
[TBL] [Abstract][Full Text] [Related]
78. U1 adaptors for the therapeutic knockdown of the oncogene pim-1 kinase in glioblastoma.
Weirauch U; Grünweller A; Cuellar L; Hartmann RK; Aigner A
Nucleic Acid Ther; 2013 Aug; 23(4):264-72. PubMed ID: 23724780
[TBL] [Abstract][Full Text] [Related]
79. Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.
Weirauch U; Beckmann N; Thomas M; Grünweller A; Huber K; Bracher F; Hartmann RK; Aigner A
Neoplasia; 2013 Jul; 15(7):783-94. PubMed ID: 23814490
[TBL] [Abstract][Full Text] [Related]
80. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
Yang Q; Chen LS; Neelapu SS; Miranda RN; Medeiros LJ; Gandhi V
Blood; 2012 Oct; 120(17):3491-500. PubMed ID: 22955922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
